Lemaitre Vascular (LMAT) Prelim. Q3 Revenue Misses Views, EPS In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
LeMaitre Vascular Announces Preliminary Q3 2018 Results
October 4, 2018 4:48 PM EDTBURLINGTON, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 and updated full year 2018 guidance, and announced a $0.07/share dividend.
Q3 2018 Preliminary Results
Sales of $24.2mm vs. $24.8mm in Q3 2017 (-3% reported, +1% organic)Gross margin of 71.4% vs. 70.8%Operating income of $4.6mm vs. $5.1mm, (-9%)Operating margin of 19% versus 20%Net income of $4.3mm vs. $5.0mm, (-14%)Earnings of $0.21 per diluted share vs. $0.25,... More